Literature DB >> 19185809

Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.

Kristin Schram1, Gary Sweeney.   

Abstract

Owing to the increased incidence of obesity and its association with heart failure, there is now great interest in elucidating the underlying molecular mechanisms linking these pathologies. Since the discovery of adipose-derived hormones and cytokines, their important regulatory role in myocardial function has emerged. The events that these adipokines can regulate include alterations in myocardial metabolism, cardiomyocyte hypertrophy, cell death, and structure and composition of the extracellular matrix. Here, we focus on the last of these and review current research demonstrating an important role for adipokines, with particular emphasis on leptin and adiponectin, in regulating matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and collagens. From this, it is clear that adipokines are capable of contributing to remodeling of the myocardial extracellular matrix, and the altered adipokine profiles observed in obese individuals may be important in the pathogenesis of heart failure. The feasibility of adipokine manipulation as a potential therapeutic treatment in preventing maladaptive cardiac remodeling is also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19185809     DOI: 10.1016/j.tcm.2008.10.001

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  26 in total

Review 1.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

Review 2.  Mechanisms of heart failure in obesity.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Alain G Bertoni
Journal:  Obes Res Clin Pract       Date:  2014-01-06       Impact factor: 2.288

Review 3.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

4.  Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.

Authors:  Nieves Gómez-Hurtado; Alejandro Domínguez-Rodríguez; Philippe Mateo; María Fernández-Velasco; Almudena Val-Blasco; Rafael Aizpún; Jessica Sabourin; Ana María Gómez; Jean-Pierre Benitah; Carmen Delgado
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

5.  C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart.

Authors:  Wei Yi; Yang Sun; Yuexing Yuan; Wayne Bond Lau; Qijun Zheng; Xiaoliang Wang; Yajing Wang; Xiying Shang; Erhe Gao; Walter J Koch; Xin-Liang Ma
Journal:  Circulation       Date:  2012-05-31       Impact factor: 29.690

6.  P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study.

Authors:  Jared W Magnani; Faye L Lopez; Elsayed Z Soliman; Richard F Maclehose; Richard S Crow; Alvaro Alonso
Journal:  Obesity (Silver Spring)       Date:  2011-04-07       Impact factor: 5.002

7.  A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload.

Authors:  David J Chess; Ramzi J Khairallah; Karen M O'Shea; Wenhong Xu; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

8.  C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation.

Authors:  Yang Sun; Wei Yi; Yuexing Yuan; Wayne Bond Lau; Dinghua Yi; Xiaoliang Wang; Yajing Wang; Hui Su; Xiaoming Wang; Erhe Gao; Walter J Koch; Xin-Liang Ma
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

Review 9.  Manifestations and mechanisms of myocardial lipotoxicity in obesity.

Authors:  A C Sletten; L R Peterson; J E Schaffer
Journal:  J Intern Med       Date:  2018-01-31       Impact factor: 8.989

Review 10.  Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases.

Authors:  Masaaki Waragai; Gilbert Ho; Yoshiki Takamatsu; Yuka Shimizu; Hiromu Sugino; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  Drug Discov Today       Date:  2018-05-07       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.